Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01445613 · ClinicalTrials.gov registry record · NA
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 1,203
- Enrollment target
NCT01445613: Completed NA study, sponsored by Abbott Medical Devices.
NCT01445613 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,203 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01445613, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,203 participants
- Enrollment target
Study Summary
The objective of the CANOPY trial is to assess the continued safety and effectiveness of the RX Acculink Carotid Stent System under commercial use in subjects at standard risk for adverse events from Carotid Endarterectomy (CEA) enrolled by physicians with a range of carotid stenting experience.
Interventions
- DEVICE RX Acculink Carotid Stent System (RX Acculink)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,203 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT01445613 record still lists
NCT01445613 is an interventional study that assigns participants to a tested intervention. Its 1,203 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 1 intervention - of which RX Acculink Carotid Stent System (RX Acculink) is the first listed.
NCT01445613 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01445613 about?
NCT01445613 is a clinical study titled "Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy". The objective of the CANOPY trial is to assess the continued safety and effectiveness of the RX Acculink Carotid Stent System under commercial use in subjects at standard risk for adverse events from Carotid Endarterectomy (CEA) enrolled by physicians with a range of carotid stenting experience.
What is the current status of trial NCT01445613?
This trial is currently completed. It is a NA study. The enrollment target is 1,203 participants. The study started on 2011-10. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01445613?
The interventions under investigation include: RX Acculink Carotid Stent System (RX Acculink) (DEVICE).
Who is sponsoring clinical trial NCT01445613?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01445613's enrollment target sits among peer trials
1,203 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07038785 · 1,204 participants
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
- NCT06535854 · 1,205 participants · NA
Prevail Global Study
- NCT07223593 · 1,205 participants · Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia